DERENZINI, ENRICO

DERENZINI, ENRICO  

Dipartimento di Scienze della Salute  

Mostra records
Risultati 1 - 20 di 92 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma] 2023 Francesca BottaEnrico DerenziniTommaso RadiceSaveria MazzaraCorrado TarellaSara RaimondiFrancesco Ceci + Article (author) -
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 2020 Derenzini, EnricoMazzara, SaveriaFabbri, MarcoFiori, StefanoCabras, AntonelloPruneri, GiancarloRambaldi, AlessandroCorradini, PaoloTarella, Corrado + Article (author) -
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma 2008 Perrotti A.Derenzini E. + Article (author) -
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma 2011 Derenzini E. + Article (author) -
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients 2008 Derenzini E. + Article (author) -
A phase ii trial of short course fludarabine, mitoxantrone, rituximab followed by 90y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma 2012 Derenzini E. + Article (author) -
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 2013 Derenzini E. + Article (author) -
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: Retrospective monocentric analysis of 14 patients 2013 Derenzini E. + Article (author) -
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy 2022 Derenzini, Enrico + Article (author) -
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis : a case report and a review of literature 2013 Derenzini, Enrico + Article (author) -
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study 2022 Derenzini, EnricoMorelli, EmanuelaPinto, Antonio + Article (author) -
Association of essential thrombocythemia and non-Hodgkin lymphoma: A single-centre experience 2009 Derenzini E. + Article (author) -
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin 2013 Derenzini E. + Article (author) -
Bendamustine: Role and evidence in lymphoma therapy, an overview 2014 Derenzini E. + Article (author) -
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors 2018 Derenzini E.Valli D. + Article (author) -
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature 2023 Carbonaro, RiccardoMazzocconi, LucaDerenzini, EnricoVeronesi, Paolo + Article (author) -
Blastic plasmacytoid dendritic cell neoplasm : State of the art and prospects 2019 Derenzini E. + Article (author) -
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: A multicenter retrospective study 2013 Derenzini E. + Article (author) -
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma : the Italian experience and results of its use in daily clinical practice outside clinical trials 2013 ANASTASIA, ANTONELLAP. CorradiniA.M. GianniE. Derenzini + Article (author) -
Bronchus-associated lymphoid tissue lymphomas : an update of a rare extranodal maltoma 2007 L. SpaggiariE. Derenzini + Article (author) -